Andrew E Beaudin1,2, Jill K Raneri3, Najib T Ayas4, Robert P Skomro5, Eric E Smith1,2, Patrick J Hanly2,3,6. 1. Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 2. Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 3. Sleep Centre, Foothills Medical Centre, Calgary, Alberta, Canada. 4. Department of Medicine, Respiratory and Critical Care Divisions, University of British Columbia, Vancouver, British Columbia, Canada. 5. Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. 6. Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Abstract
STUDY OBJECTIVES: Although cognitive impairment in obstructive sleep apnea (OSA) is primarily attributed to intermittent hypoxemia and sleep fragmentation, hypercapnia may also play a role in patients whose OSA is complicated by hypoventilation. This study investigated the impact of hypercapnia on cognitive function in severe sleep-disordered breathing (OSA accompanied by hypoventilation). METHODS: Patients with severe OSA (apnea-hypopnea index >30 events/h; n = 246) underwent evaluation for accompanying hypoventilation with polysomnography that included continuous transcutaneous carbon dioxide (TcCO2) monitoring and awake arterial blood gas analysis. Patients were categorized as having no hypoventilation (n = 84), isolated sleep hypoventilation (n = 40), or awake hypoventilation (n = 122). Global cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA), memory with the Rey Auditory Verbal Learning Test (RAVLT), and processing speed with the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV), Digit Symbol Coding subtest (DSC). RESULTS: Apnea-hypopnea index was similar across groups (P = .15), but the sleep and awake hypoventilation groups had greater nocturnal hypoxemia compared with the no-hypoventilation group (P < .01). Within all groups, mean MoCA scores were < 26, which is the validated threshold to indicate mild cognitive impairment; RAVLT scores were lower than age-matched norms only in the awake-hypoventilation group (P ≤ .01); and DSC scores were lower than age-matched norms within all groups (P < .01). In multivariable regression analyses, higher arterial partial pressure of carbon dioxide (PaCO2) and TcCO2 during wakefulness were associated with lower MoCA and DSC scores (P ≤ .03), independent of confounders including overlap syndrome (OSA + chronic obstructive pulmonary disease). CONCLUSIONS: Awake hypoventilation is associated with greater deficits in cognitive function in patients with severe sleep-disordered breathing. CITATION: Beaudin AE, Raneri JK, Ayas NT, Skomro RP, Smith EE, Hanly PJ; on behalf of Canadian Sleep and Circadian Network. Contribution of hypercapnia to cognitive impairment in severe sleep-disordered breathing. J Clin Sleep Med. 2022;18(1):245-254.
STUDY OBJECTIVES: Although cognitive impairment in obstructive sleep apnea (OSA) is primarily attributed to intermittent hypoxemia and sleep fragmentation, hypercapnia may also play a role in patients whose OSA is complicated by hypoventilation. This study investigated the impact of hypercapnia on cognitive function in severe sleep-disordered breathing (OSA accompanied by hypoventilation). METHODS: Patients with severe OSA (apnea-hypopnea index >30 events/h; n = 246) underwent evaluation for accompanying hypoventilation with polysomnography that included continuous transcutaneous carbon dioxide (TcCO2) monitoring and awake arterial blood gas analysis. Patients were categorized as having no hypoventilation (n = 84), isolated sleep hypoventilation (n = 40), or awake hypoventilation (n = 122). Global cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA), memory with the Rey Auditory Verbal Learning Test (RAVLT), and processing speed with the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV), Digit Symbol Coding subtest (DSC). RESULTS: Apnea-hypopnea index was similar across groups (P = .15), but the sleep and awake hypoventilation groups had greater nocturnal hypoxemia compared with the no-hypoventilation group (P < .01). Within all groups, mean MoCA scores were < 26, which is the validated threshold to indicate mild cognitive impairment; RAVLT scores were lower than age-matched norms only in the awake-hypoventilation group (P ≤ .01); and DSC scores were lower than age-matched norms within all groups (P < .01). In multivariable regression analyses, higher arterial partial pressure of carbon dioxide (PaCO2) and TcCO2 during wakefulness were associated with lower MoCA and DSC scores (P ≤ .03), independent of confounders including overlap syndrome (OSA + chronic obstructive pulmonary disease). CONCLUSIONS: Awake hypoventilation is associated with greater deficits in cognitive function in patients with severe sleep-disordered breathing. CITATION: Beaudin AE, Raneri JK, Ayas NT, Skomro RP, Smith EE, Hanly PJ; on behalf of Canadian Sleep and Circadian Network. Contribution of hypercapnia to cognitive impairment in severe sleep-disordered breathing. J Clin Sleep Med. 2022;18(1):245-254.
Authors: Sheila Sivam; Joseph Poon; Keith K H Wong; Brendon J Yee; Amanda J Piper; Angela L D'Rozario; David Wang; Ronald R Grunstein Journal: Sleep Date: 2020-02-13 Impact factor: 5.849
Authors: Michael A Grandner; Nirav P Patel; Philip R Gehrman; Michael L Perlis; Allan I Pack Journal: Sleep Med Rev Date: 2009-11-06 Impact factor: 11.609
Authors: Andrew E Beaudin; Jill K Raneri; Najib T Ayas; Robert P Skomro; Nurit Fox; A J Marcus Hirsch Allen; Matthew W Bowen; Andrhea Nocon; Emma J Lynch; Meng Wang; Eric E Smith; Patrick J Hanly Journal: Ann Am Thorac Soc Date: 2021-05
Authors: Ram A Sharma; Andrew W Varga; Omonigho M Bubu; Elizabeth Pirraglia; Korey Kam; Ankit Parekh; Margaret Wohlleber; Margo D Miller; Andreia Andrade; Clifton Lewis; Samuel Tweardy; Maja Buj; Po L Yau; Reem Sadda; Lisa Mosconi; Yi Li; Tracy Butler; Lidia Glodzik; Els Fieremans; James S Babb; Kaj Blennow; Henrik Zetterberg; Shou E Lu; Sandra G Badia; Sergio Romero; Ivana Rosenzweig; Nadia Gosselin; Girardin Jean-Louis; David M Rapoport; Mony J de Leon; Indu Ayappa; Ricardo S Osorio Journal: Am J Respir Crit Care Med Date: 2018-04-01 Impact factor: 30.528
Authors: Magdy K Younes; Andrew E Beaudin; Jill K Raneri; Beth J Gerardy; Patrick J Hanly Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324